Japanese REal-world data for treatment of afatinib (GIotrif®) in first-line setting and Subsequent Therapies for patients with advanced EGFR mutation-positive lung adenocarcinoma (J-REGISTER)

Study protocol

Initial protocol

1200-0322_NIS_protocol.pdf

English (1.38 MB - PDF) View document

Updated protocol

1200-0322_protocol_redacted.pdf

First published: 15/12/2025

English (1.37 MB - PDF) View document

Study results

No information provided.

Study report

Abstract of study report

1200-0322_Synopsis.pdf

English (252.95 KB - PDF) View document

Secondary tabs